{
    "2018-12-28": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Will A New Approval Help This Medical Stock Approach A Breakout?",
                "features": {
                    "keywords": [
                        "new approval",
                        "medical stock",
                        "approach",
                        "breakout"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Top Analyst Reports for Merck, Abbott & Lockheed Martin",
                "features": {
                    "keywords": [
                        "analyst reports",
                        "Merck",
                        "Abbott",
                        "Lockheed Martin"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "defense"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}